Wolverine Trading’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $50.3M | Sell |
665,600
-700
| -0.1% | -$48K | 0.04% | 314 |
|
|
2025
Q2 | $45.6M | Buy |
+666,300
| New | +$43.7M | 0.05% | 269 |
|
|
2025
Q1 | – | Sell |
-779,500
| Closed | -$34.3M | – | 4926 |
|
|
2024
Q4 | $34.3M | Buy |
779,500
+215,600
| +38% | +$12.1M | 0.03% | 317 |
|
|
2024
Q3 | $34.6M | Sell |
563,900
-19,300
| -3% | -$1.13M | 0.04% | 284 |
|
|
2024
Q2 | $34.4M | Buy |
583,200
+152,400
| +35% | +$9.53M | 0.04% | 268 |
|
|
2024
Q1 | $34.4M | Sell |
430,800
-48,700
| -10% | -$3.72M | 0.03% | 279 |
|
|
2023
Q4 | $37.9M | Sell |
479,500
-395,400
| -45% | -$28.1M | 0.04% | 278 |
|
|
2023
Q3 | $61.1M | Buy |
874,900
+339,600
| +63% | +$24.1M | 0.06% | 129 |
|
|
2023
Q2 | $36.8M | Buy |
535,300
+53,300
| +11% | +$3.79M | 0.04% | 219 |
|
|
2023
Q1 | $36M | Buy |
482,000
+141,200
| +41% | +$11.8M | 0.06% | 209 |
|
|
2022
Q4 | $31.8M | Sell |
340,800
-139,300
| -29% | -$13.4M | 0.05% | 303 |
|
|
2022
Q3 | $46.6M | Buy |
480,100
+46,000
| +11% | +$4.55M | 0.07% | 149 |
|
|
2022
Q2 | $40.5M | Sell |
434,100
-13,400
| -3% | -$1.31M | 0.07% | 158 |
|
|
2022
Q1 | $46.3M | Sell |
447,500
-71,000
| -14% | -$7.46M | 0.06% | 198 |
|
|
2021
Q4 | $53.8M | Buy |
518,500
+46,100
| +10% | +$4.26M | 0.06% | 204 |
|
|
2021
Q3 | $41M | Sell |
472,400
-157,800
| -25% | -$13.2M | 0.05% | 287 |
|
|
2021
Q2 | $52.6M | Buy |
630,200
+158,200
| +34% | +$13M | 0.08% | 176 |
|
|
2021
Q1 | $35.9M | Sell |
472,000
-585,200
| -55% | -$42.6M | 0.05% | 243 |
|
|
2020
Q4 | $71.6M | Buy |
1,057,200
+179,300
| +20% | +$11.7M | 0.11% | 107 |
|
|
2020
Q3 | $50.5M | Buy |
877,900
+139,600
| +19% | +$8.69M | 0.12% | 103 |
|
|
2020
Q2 | $47.6M | Sell |
738,300
-361,200
| -33% | -$22.7M | 0.13% | 86 |
|
|
2020
Q1 | $65.6M | Buy |
1,099,500
+576,700
| +110% | +$38.5M | 0.2% | 62 |
|
|
2019
Q4 | $38.5M | Buy |
522,800
+9,500
| +2% | +$667K | 0.09% | 159 |
|
|
2019
Q3 | $31.9M | Buy |
513,300
+63,300
| +14% | +$3.75M | 0.09% | 158 |
|
|
2019
Q2 | $24.5M | Buy |
450,000
+7,400
| +2% | +$399K | 0.07% | 233 |
|
|
2019
Q1 | $23.9M | Buy |
442,600
+97,100
| +28% | +$5.99M | 0.07% | 211 |
|
|
2018
Q4 | $22.5M | Buy |
345,500
+16,800
| +5% | +$1.25M | 0.06% | 221 |
|
|
2018
Q3 | $25.9M | Buy |
328,700
+210,900
| +179% | +$15.1M | 0.06% | 232 |
|
|
2018
Q2 | $7.33M | Hold |
117,800
| – | – | 0.02% | 653 |
|
|
2018
Q1 | $7.33M | Sell |
117,800
-2,100
| -2% | -$151K | 0.02% | 653 |
|
|
2017
Q4 | $8.69M | Sell |
119,900
-35,500
| -23% | -$2.58M | 0.03% | 565 |
|
|
2017
Q3 | $12.6M | Buy |
+155,400
| New | +$12.3M | 0.05% | 346 |
|
|
2017
Q2 | – | Sell |
-319,200
| Closed | -$25.2M | – | 4359 |
|
|
2017
Q1 | $25.2M | Sell |
319,200
-211,800
| -40% | -$16.9M | 0.14% | 133 |
|
|
2016
Q4 | $41.9M | Buy |
531,000
+164,400
| +45% | +$13.3M | 0.21% | 84 |
|
|
2016
Q3 | $32.8M | Buy |
366,600
+86,100
| +31% | +$8.13M | 0.15% | 126 |
|
|
2016
Q2 | $26.5M | Buy |
+280,500
| New | +$28M | 0.15% | 125 |
|
Other funds holding CVS
Wolverine Trading's CVS Position: Q3 2025 in Review
Wolverine Trading opened a new position in CVS Health (CVS) in Q3 2025: 12,206 shares worth $922K. The stake represents ﹤0.01% of the portfolio and ranks #2984 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in CVS as recently as Q4 2024.
Wolverine Trading first reported a position in CVS in Q2 2016 and has held it in 33 quarters since. The position peaked at $29.4M in Q4 2019. 1,837 funds tracked by Wall St. Rank hold CVS as of Q3 2025.
- Wolverine Trading held 12,206 shares of CVS Health worth $922K as of Q3 2025.
- CVS Health was a new Wolverine Trading position in Q3 2025.
- CVS Health made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2984 holding.
- Wolverine Trading first reported a position in CVS Health in Q2 2016 and has held it in 33 quarters since.
- Wolverine Trading's CVS Health position peaked at $29.4M in Q4 2019.
- 1,837 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.